South San Francisco, California-based 23andMe filed for bankruptcy last month, seeking to sell its business at auction after a decline in c...

Regeneron to rescue 23andMe in a $256 million deal, raising major questions about DNA privacy, genetic data ownership, and what happens to ...

Biocon Biologics has reached a settlement and licensing agreement with Regeneron, clearing the way for the US commercialization of Yesafili...

Biocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalm...

Scientists are embarking on a project to collect genetic material from 500,000 people of African ancestry in order to create the world's la...

Among them, the five Indian American include Siddhu Pachipala from Texas, Lavanya Natarajan and Ishika Nag from Florida, Neel Moudgal from ...

The company said the participants in the trial were unvaccinated adults older than 18 years with confirmed exposure to a person with the co...

Regeneron and Roche's antibody cocktail has also received emergency use approval in India, and will be distributed by drugmaker Cipla. The ...

The results of the Phase 3 trial showed that the combination of the antibodies casirivimab and imdevimab "reduced hospitalisation or death ...

The money will enable the United Nations children's agency UNICEF to buy up to 3 million courses of antibody treatments once they are appro...

The new purchase is part of a U.S. government deal to secure nearly 1 million doses of Lilly's bamlanivimab, a treatment similar to Regener...

Tests in animals suggest that antibody drugs work best when given early in infection to lower the amount of virus, he said. Once someone is...

Independent monitors had paused enrolment in the study two weeks ago because of a possible safety issue. But on Monday, the National Instit...

The Food and Drug Administration OK'd the drug developed by Regeneron Pharmaceuticals for treating adults and children with the Zaire Ebola...

More recently, scientists have developed treatments called monoclonal antibodies -- antibodies that can be isolated and manufactured in lar...

The FDA approved Dupixent (dupilumab), is the first targeted biologic therapy for adults with moderate-to-severe atopic dermatitis.

"The Biocon employer brand has been growing stronger with each passing year, and our increased success in attracting talent is a testimony ...